詳細信息
- ;鹽酸依立替康三水合物;L-(+)-N-[4-[[(2,4-二氨基-6-蝶啶基)甲氨基]苯甲三水合物;三水鹽酸伊立替康;鹽酸三水伊立替康三水合物;伊立替康鹽酸鹽三水合物;鹽酸伊立替康三水化合物;L-(+)-N-[4-[[(2,4-二氨基-6-蝶啶基)甲氨基]苯甲三水合物;
- Irinotecan hydrochloride trihydrate
- ;(+)-7-Ethyl-10-hydroxycamptothecine 10-(1,4'-bipiperidine)-1'-carboxylate, monohydrochloride, trihydrate;Camptosar;Irinotecan HCl trihydrate;(1,4'-Bipiperidine)-1'-carboxylic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, monohydrochloride, trihydrate, (S)-;(1,4'-bipiperidine)-1'-carboxylicacid,4,11-diethyl-3,4,12,14-tetrahydro-4-hyd monohydrochloride, trihydrate;roxy-3,14-dioxo-1h-pyrano(3',4',6,7)indolizino(1,2-b)quinolin-9-ylester,mono;trihydrate,(s)-hydrochlorid trihydrate;irinotecan monohydrochloride trihydrate;[1,4'-bipiperidine]-1'-carboxylic acid (s)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano;[3',4',6,7]indolizino[1,2-b]quinolin-9-yl ester, hcl trihydrate;(s)-[1,4'-bipiperidine]-1'-carboxylic acid 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano;[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride trihydrate;irinotecanhydrochloridetrihydrate(cpt-11);(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate trihydrate hydrochloride;(+)-7-Ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin, monohydrochloride, trihydrate;(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride trihydrate;(S)-[1,4'-Bipiperidine]-1'-carboxylic acid 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride trihydrate;[1,4'-Bipiperidine]-1'-carboxylic acid,4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride,trihydrate, (S)-;[1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, hydrochloride, hydrate (1:1:3);
- InChI=1/C33H38N4O6.ClH/c1-3-22-23-9-8-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)16-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1
- 250-256℃ (dec.)
- 伊立替康 產(chǎn)品名稱:鹽、、酸伊立替康三水合物 中文別名: 鹽、、酸依立替康三水合物; ; 三水鹽、、酸伊立替康 CAS 號 :136572-09-3 英文名稱:Irinotecan hydrochloride trihydrate 分子式 :C33H38N4O6.HCL.3(H2O) 分子量 :677.19 熔 點 :250~256℃ 含 量 :≥99% 性 狀 :淡黃疏松狀粉末 用 途 :主要用于治療消化系統(tǒng)腫、、瘤,伊立替康是一種經(jīng)過化學結(jié)構(gòu)修飾的天然喜樹堿的衍生物。它是療效確切、毒副作用較小的新型抗癌藥物,主要用于治療肺癌、結(jié)直腸癌、胃癌、子宮癌、卵巢癌等癌癥
- 包裝:1公斤/袋
產(chǎn)地:湖北武漢
供應地:本廠 - CAS NO:136572-09-3
產(chǎn)品規(guī)格:027-87182808
免責聲明:以上所展示的信息由企業(yè)自行提供,內(nèi)容的真實性、準確性和合法性由發(fā)布企業(yè)負責,化工網(wǎng)對此不承擔任何保證責任。我們原則上建議您選擇化工網(wǎng)高級會員或VIP會員。